Evidence map›Paper›PMID 37177043›Full record

ReviewNanomaterials (Basel, Switzerland)2023

Recent Advances in ZnO Nanomaterial-Mediated Biological Applications and Action Mechanisms.

Jiani Xie, Huilun Li, Tairan Zhang, Bokai Song, Xinhui Wang, Zhanjun Gu

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. FeScientific reports · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiani XieCollege of Food and Biological Engineering, Chengdu University, Chengdu 610106, China.
Huilun LiCollege of Food and Biological Engineering, Chengdu University, Chengdu 610106, China.
Tairan ZhangCollege of Food and Biological Engineering, Chengdu University, Chengdu 610106, China.
Bokai SongCollege of Food and Biological Engineering, Chengdu University, Chengdu 610106, China.
Xinhui WangCollege of Food and Biological Engineering, Chengdu University, Chengdu 610106, China.
Zhanjun GuCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China.ORCID 0000-0003-3717-2423

Funding

Natural Science Foundation of Sichuan province 2023NSFSC1452Open Fund Project of Key Laboratory of Chemistry in Ethnic Medicine Resource (Yunnan Minzu University), State Ethnic Affairs Commission & Ministry of Education MZY2208Talent Engineering Research Initiation Project of Chengdu University under Grant 2081920047
6 · The paper itself

Abstract

In recent years, with the deepening research, metal zinc oxide (ZnO) nanomaterials have become a popular research object in the biological field, particularly in biomedicine and food safety, which is attributed to their unique physicochemical properties such as high surface area and volume ratio, luminescence effect, surface characteristics and biological activities. Herein, this review provides a detailed overview of the ZnO nanomaterial-mediated biological applications that involve anti-bacterial, anti-tumor, anti-inflammation, skin care, biological imaging and food packaging applications. Importantly, the corresponding action mechanisms of ZnO nanomaterials are pointed. Additionally, the structure and structure-dependent physicochemical properties, the common synthesis methods and the biosafety of ZnO nanoparticles are revealed in brief. Finally, the significance and future challenges of ZnO nanomaterial applications are concluded.

Indexed as

action mechanismbiological applicationsnanomaterialsZnO

Identifiers

PMID37177043
PMCPMC10180283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.